Serum levels of FGF 19 and FGF 21 for subjects during the three periods were intergraded and the correlations with indicators of diabetes and NAFLD are shown in Figure 2. The gene discussed is FGF19; the disease is metabolic dysfunction-associated steatotic liver disease.